NovaLead's Patented Repurposed Drug receives approval from CDSCO for the treatment of Diabetic Foot Ulcer (DFU) for India market

New Delhi [India], July 25: NovaLead Pharma Private Limited (NovaLead), the pioneer of drug repurposing in India announced today that the drug regulator in India, CDSCO has approved their patented Repurposed Drug for treatment of Diabetic Foot Ulcer (DFU) which is a global unmet medical need.